ADMA Biologics ADMA Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's change in AR?
- ADMA Biologics (ADMA) reported change in AR of -$22.57M in Q1 2026.
- How has ADMA Biologics's change in AR changed year-over-year?
- ADMA Biologics's change in AR decreased by 145.7% year-over-year, from $49.41M to -$22.57M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.